Correlation Between Lixte Biotechnology and Reviva Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Lixte Biotechnology and Reviva Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Lixte Biotechnology and Reviva Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Lixte Biotechnology Holdings and Reviva Pharmaceuticals Holdings, you can compare the effects of market volatilities on Lixte Biotechnology and Reviva Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Lixte Biotechnology with a short position of Reviva Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Lixte Biotechnology and Reviva Pharmaceuticals.
Diversification Opportunities for Lixte Biotechnology and Reviva Pharmaceuticals
0.2 | Correlation Coefficient |
Modest diversification
The 3 months correlation between Lixte and Reviva is 0.2. Overlapping area represents the amount of risk that can be diversified away by holding Lixte Biotechnology Holdings and Reviva Pharmaceuticals Holding in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Reviva Pharmaceuticals and Lixte Biotechnology is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Lixte Biotechnology Holdings are associated (or correlated) with Reviva Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Reviva Pharmaceuticals has no effect on the direction of Lixte Biotechnology i.e., Lixte Biotechnology and Reviva Pharmaceuticals go up and down completely randomly.
Pair Corralation between Lixte Biotechnology and Reviva Pharmaceuticals
Assuming the 90 days horizon Lixte Biotechnology Holdings is expected to generate 2.01 times more return on investment than Reviva Pharmaceuticals. However, Lixte Biotechnology is 2.01 times more volatile than Reviva Pharmaceuticals Holdings. It trades about 0.05 of its potential returns per unit of risk. Reviva Pharmaceuticals Holdings is currently generating about 0.02 per unit of risk. If you would invest 3.20 in Lixte Biotechnology Holdings on August 28, 2024 and sell it today you would lose (0.41) from holding Lixte Biotechnology Holdings or give up 12.81% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Lixte Biotechnology Holdings vs. Reviva Pharmaceuticals Holding
Performance |
| Timeline |
| Lixte Biotechnology |
| Reviva Pharmaceuticals |
Lixte Biotechnology and Reviva Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Lixte Biotechnology and Reviva Pharmaceuticals
The main advantage of trading using opposite Lixte Biotechnology and Reviva Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Lixte Biotechnology position performs unexpectedly, Reviva Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Reviva Pharmaceuticals will offset losses from the drop in Reviva Pharmaceuticals' long position.| Lixte Biotechnology vs. Reviva Pharmaceuticals Holdings | Lixte Biotechnology vs. CannBioRx Life Sciences |
| Reviva Pharmaceuticals vs. Protalix Biotherapeutics | Reviva Pharmaceuticals vs. Eyepoint Pharmaceuticals | Reviva Pharmaceuticals vs. Sellas Life Sciences | Reviva Pharmaceuticals vs. In8bio Inc |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Aroon Oscillator module to analyze current equity momentum using Aroon Oscillator and other momentum ratios.
Other Complementary Tools
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Stocks Directory Find actively traded stocks across global markets |